DCM
RETA

Driehaus Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Driehaus Capital Management’s Portfolio RETA Stock Details RETA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$9.68M Buy
2020
Q2 		– Sell
2020
Q1 		$1.81M Sell
2019
Q4 		$3.33M Sell
2019
Q3 		$17.1M Sell
2019
Q2 		$22.3M Buy
2019
Q1 		$12.4M Buy
2018
Q4 		$7.2M Sell
2018
Q3 		$15.3M Buy